Memorial Sloan Kettering Cancer Center
- 2nd Annual Symposium on Advanced Therapeutics for Brain Metastasis
- Myeloma
- Leukemia
- Lymphoma
- Hematologic Transplantation and Malignancies
- Breast
- Lung
- Gastrointestinal
- Genitourinary
- Gynecologic
- Skin
- Head and Neck
- Brain
- General Oncology
- Palliative Care
- MPN
- COVID-19
- Events
Playback speed
10 seconds
ASCO 2022 HR+ Breast Cancer Updates
By
Nebraska Oncology Society
FEATURING
Chau Dang
By
Nebraska Oncology Society
FEATURING
Chau Dang
595 views
July 6, 2022
This presentation was recorded prior to fam-trastuzumab deruxtecan-nxki (Enhertu) receiving FDA approval on August 5, ...
read more ↘ 2022, for adult patients with HER2-low MBC who have received a prior chemotherapy in the metastatic setting or developed disease recurrence during or within six months of completing adjuvant chemotherapy.
↖ read less
read more ↘ 2022, for adult patients with HER2-low MBC who have received a prior chemotherapy in the metastatic setting or developed disease recurrence during or within six months of completing adjuvant chemotherapy.
↖ read less
Comments 0
Login to view comments.
Click here to Login
Breast